Insider Transactions in Q2 2022 at Outlook Therapeutics, Inc. (OTLK)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
C Russell Trenary Iii CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
19,925
+26.62%
|
$19,925
$1.06 P/Share
|
|
Jun 21
2022
|
Terry Dagnon Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.85%
|
$10,000
$1.05 P/Share
|
|
Apr 21
2022
|
Bio Lexis Pte Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
27,982,529
-54.91%
|
-
|
|
Apr 21
2022
|
Faisal Ghiath Sukhtian |
BUY
Other acquisition or disposition
|
Indirect |
27,982,529
+33.39%
|
-
|